| The contribution of de novo coding mutations to autism spectrum disorder I Iossifov, BJ O’roak, SJ Sanders, M Ronemus, N Krumm, D Levy, ... Nature 515 (7526), 216, 2014 | 2676 | 2014 |
| De novo gene disruptions in children on the autistic spectrum I Iossifov, M Ronemus, D Levy, Z Wang, I Hakker, J Rosenbaum, ... Neuron 74 (2), 285-299, 2012 | 1687 | 2012 |
| Indel variant analysis of short-read sequencing data with Scalpel H Fang, EA Bergmann, K Arora, V Vacic, MC Zody, I Iossifov, JA O'Rawe, ... Nature Protocols 11 (12), 2529-2548, 2016 | 119 | 2016 |
| Genome-wide somatic variant calling using localized colored de Bruijn graphs G Narzisi, A Corvelo, K Arora, EA Bergmann, M Shah, R Musunuri, ... Communications Biology 1 (1), 20, 2018 | 106 | 2018 |
| Genome-wide somatic variant calling using localized colored de Bruijn graphs G Narzisi, A Corvelo, K Arora, EA Bergmann, M Shah, R Musunuri, ... Communications Biology 1 (1), 20, 2018 | 106 | 2018 |
| Conpair: concordance and contamination estimator for matched tumor–normal pairs EA Bergmann, BJ Chen, K Arora, V Vacic, MC Zody Bioinformatics 32 (20), 3196-3198, 2016 | 78 | 2016 |
| Comparing sequencing assays and human-machine analyses in actionable genomics for glioblastoma KO Wrzeszczynski, MO Frank, T Koyama, K Rhrissorrakrai, N Robine, ... Neurology Genetics 3 (4), e164, 2017 | 44 | 2017 |
| State MW, Wigler M I Iossifov, BJ O'Roak, SJ Sanders, M Ronemus, N Krumm, D Levy, ... The contribution of de novo coding mutations to autism spectrum disorder …, 2014 | 37 | 2014 |
| Integrative genetic analysis of mouse and human AML identifies cooperating disease alleles MA Hatlen, K Arora, V Vacic, EA Grabowska, W Liao, B Riley-Gillis, ... Journal of Experimental Medicine 213 (1), 25-34, 2016 | 29 | 2016 |
| A family with 3460G> A and 11778G> A mutations and haplogroup analysis of Polish Leber hereditary optic neuropathy patients K Tonska, M Kurzawa, AM Ambroziak, M Korwin-Rujna, JP Szaflik, ... Mitochondrion 8 (5-6), 383-388, 2008 | 26 | 2008 |
| Correction to: Sequencing and curation strategies for identifying candidate glioblastoma treatments MO Frank, T Koyama, K Rhrissorrakrai, N Robine, F Utro, AK Emde, ... BMC medical genomics 12 (1), 1-1, 2019 | 11 | 2019 |
| Sequencing and curation strategies for identifying candidate glioblastoma treatments MO Frank, T Koyama, K Rhrissorrakrai, N Robine, F Utro, AK Emde, ... BMC Medical Genomics 12 (1), 56, 2019 | 11 | 2019 |
| Lancet: genome-wide somatic variant calling using localized colored DeBruijn graphs G Narzisi, A Corvelo, K Arora, E Bergmann, M Shah, R Musunuri, ... bioRxiv, 196311, 2017 | 4 | 2017 |
| NYGC glioblastoma clinical outcomes pilot study: Discovering therapeutic potential in glioblastoma through integrative genomics KO Wrzeszczynski, N Robine, V Vacic, AK Emde, BJ Chen, W Liao, ... Cancer Research 76 (14 Supplement), 4497-4497, 2016 | 1 | 2016 |
| RNA-Seq in the NYGC GBM Clinical Outcomes Pilot Study BJR Chen, N Robine, K Wrzeszczynski, V Vacic, AK Emde, K Arora, ... Cancer Research 76 (14 Supplement), 4498-4498, 2016 | | 2016 |
| Mutations References I Iossifov, M Ronemus, D Levy, Z Wang, I Hakker, J Rosenbaum, ... Neuron 74 (2), 285-99, 2012 | | 2012 |
